Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.

about

Citrus junos Tanaka peel ameliorates hepatic lipid accumulation in HepG2 cells and in mice fed a high-cholesterol diet.Variable phenotypic expression of nonsense mutation p.Thr5* in the APOE gene RNA-Mediated Gene Activation: Identifying a Candidate RNA for Preclinical Development.

P2860

Q36212235-6FD35C1D-4784-4890-A703-75E539BD74A5 Q41662550-E7EF3C06-0FE8-4CA6-8595-0755E762DBE6 Q48746883-BD69F5C9-2E35-447F-ADE3-89DAB129CE36

P2860

Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.

Item

http://www.wikidata.org/entity/Q38673894

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapeutic Management of Fami ...... t and Emerging Drug Therapies.

@en

type

Item

label

Therapeutic Management of Fami ...... t and Emerging Drug Therapies.

@en

prefLabel

Therapeutic Management of Fami ...... t and Emerging Drug Therapies.

@en

P1476

Therapeutic Management of Fami ...... t and Emerging Drug Therapies.

@en

P2093

Emily M Scopelliti

http://www.w3.org/2001/XMLSchema#string

Julie Savelloni

http://www.w3.org/2001/XMLSchema#string

Roshni S Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.

Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia.

P304

1189-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1672

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26684558

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia

Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.

about

P2860

P2860

Therapeutic Management of Familial Hypercholesterolemia: Current and Emerging Drug Therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921